Cargando…
Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer
PURPOSE: Serum levels of the polypeptide chemokine C-C motif ligand 2 (CCL2) have previously shown potential as a prostate cancer diagnostic and prognostic biomarker. Plasma CCL2 levels may be superior to serum levels as a biomarker because of their potentially lower signal-to-noise ratio. MATERIALS...
Autores principales: | Lund, Martin, Pedersen, Torben B, Feddersen, Søren, Østergaard, Louise D, Poulsen, Charlotte A, Enggaard, Christian, Poulsen, Mads H A, Lund, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846609/ https://www.ncbi.nlm.nih.gov/pubmed/35178362 http://dx.doi.org/10.2147/RRU.S346978 |
Ejemplares similares
-
Plasma levels of monokine induced by interferon-gamma/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine/chemokine (C-C motif) ligand 17 in children with Kawasaki disease
por: Feng, Siqi, et al.
Publicado: (2015) -
Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19
por: Liu, Lina, et al.
Publicado: (2018) -
Prostate cancer: a review of active surveillance
por: Lund, Lars, et al.
Publicado: (2014) -
The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
por: Zajkowska, Monika, et al.
Publicado: (2022) -
Endonuclease V Regulates Atherosclerosis Through C‐C Motif Chemokine Ligand 2‐Mediated Monocyte Infiltration
por: Kong, Xiang Yi, et al.
Publicado: (2021)